Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis (Q79736443)
Jump to navigation
Jump to search
scientific article published on 07 February 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis |
scientific article published on 07 February 2007 |
Statements
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis (English)
G Morozzi
M Fabbroni
F Bellisai
S Cucini
A Simpatico
7 February 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference